Table 1.
Differences between ILD and those without ILD in SRP-IMNM
| Characteristic | ILD patients (n = 27) | Patients without ILD (n = 33) | p value |
|---|---|---|---|
| Female/male | 22/5 | 23/10 | > 0.05 |
| Smoking history | 3/27 (11.1%) | 2/33 (6.1%) | > 0.05 |
| Age (years) | 48.6 ± 14.4 | 41.2 ± 15.4 | < 0.05 |
| Arthritis | 1/27 (3.7%) | 3/33 (9.1%) | > 0.05 |
| Fever | 3/27 (11.1%) | 1/33 (3.0%) | > 0.05 |
| Myalgia | 11/27 (40.7%) | 10/33 (30.3%) | > 0.05 |
| Dysphagia | 14/27 (51.9%) | 7/33 (21.2%) | < 0.05 |
| AST (U/L) | 101.2 ± 89.5 | 130.8 ± 113.0 | > 0.05 |
| ALT (U/L) | 126.5 ± 102.9 | 158.7 ± 105.8 | > 0.05 |
| CK (U/L) | 2520.4 ± 2409.1 | 3493.4 ± 3161.7 | > 0.05 |
| LDH (U/L) | 564.8 ± 316.7 | 705.1 ± 390.6 | > 0.05 |
| Serum ferrtin (ng/L) | 162.9 ± 142.5 | 184.5 ± 178.4 | > 0.05 |
| ANA positive | 24/27 (88.9%) | 27/33 (81.8%) | > 0.05 |
| Ro-52 | 13/27 (48.1%) | 11/33 (33.3%) | > 0.05 |
| SSA | 4/27 (14.8%) | 4/33 (12.1%) | > 0.05 |
LDH, lactate dehydrogenase; ALT, alanine transaminase; AST, aspartate transaminase; CK, creatine kinase